Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wicki

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Neuroimage. Clinical|December 3, 2020
Age-dependent cut-offs for pathological deep gray matter and thalamic volume loss using Jacobian integrationRoland Opfer, Julia Krüger, Lothar Spies, et al.
The Journal of Biological Chemistry|December 5, 1986
Expression of platelet glycoprotein Ib alpha in HEL cellsN Kieffer, N Debili, A Wicki, et al.
Neuroimage|May 1, 2025
Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other facesDila Suay, Helena D Aicher, Micheal Kometer, et al.
ESMO Open|January 8, 2022
Targeting immunoliposomes to EGFR-positive glioblastomaB Kasenda, D König, M Manni, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancersS Pradervand, N Freundler, B Gosztonyi, et al.
The International Journal of Neuropsychopharmacology|January 8, 2025
Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trialMichael J Mueller, Helena D Aicher, Dario A Dornbierer, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Neuroimage. Clinical|December 3, 2020
Age-dependent cut-offs for pathological deep gray matter and thalamic volume loss using Jacobian integrationRoland Opfer, Julia Krüger, Lothar Spies, et al.
The Journal of Biological Chemistry|December 5, 1986
Expression of platelet glycoprotein Ib alpha in HEL cellsN Kieffer, N Debili, A Wicki, et al.
Neuroimage|May 1, 2025
Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other facesDila Suay, Helena D Aicher, Micheal Kometer, et al.
ESMO Open|January 8, 2022
Targeting immunoliposomes to EGFR-positive glioblastomaB Kasenda, D König, M Manni, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancersS Pradervand, N Freundler, B Gosztonyi, et al.
The International Journal of Neuropsychopharmacology|January 8, 2025
Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trialMichael J Mueller, Helena D Aicher, Dario A Dornbierer, et al.
Pageof 2